about
MRI Virtual Biopsy and Treatment of Brain Metastatic Tumors with Targeted Nanobioconjugates: Nanoclinic in the BrainUsefulness of double dose contrast-enhanced magnetic resonance imaging for clear delineation of gross tumor volume in stereotactic radiotherapy treatment planning of metastatic brain tumors: a dose comparison study.Assessment of irradiated brain metastases using dynamic contrast-enhanced magnetic resonance imaging.Assessment of stereotactic radiosurgery treatment response for brain metastases using MRI based diffusion index.The added value of double dose gadolinium enhanced 3D T2 fluid-attenuated inversion recovery for evaluating small brain metastases.Overcoming the challenges in the effective delivery of chemotherapies to CNS solid tumors.Temozolomide and/or Erlotinib in the Treatment of Lung Cancer Patients With Progressive Central Nervous System Metastases.Recent progress towards development of effective systemic chemotherapy for the treatment of malignant brain tumors.Veliparib in combination with whole-brain radiation therapy for patients with brain metastases from non-small cell lung cancer: results of a randomized, global, placebo-controlled study.Functional role of endothelial adhesion molecules in the early stages of brain metastasis.Cystic brain metastasis is associated with poor prognosis in patients with advanced breast cancer.Dynamic contrast-enhanced MRI perfusion for differentiating between melanoma and lung cancer brain metastases.Therapy and prophylaxis of brain metastases.Health-related quality of life in patients with brain tumors: limitations and additional outcome measures.Update on bevacizumab and other angiogenesis inhibitors for brain cancer.Surgical treatment of brain tumor coexisted with intracranial aneurysm--case series and review of the literature.Embracing rejection: Immunologic trends in brain metastasis.Veliparib in combination with whole brain radiation therapy in patients with brain metastases: results of a phase 1 study.A new TNM classification for breast cancer to meet the demands of the present and the challenges of the future.Ex-vivo HRMAS of adult brain tumours: metabolite quantification and assignment of tumour biomarkers.Differentiation of solitary brain metastasis from glioblastoma multiforme: a predictive multiparametric approach using combined MR diffusion and perfusion.Characterizing hypervascular and hypovascular metastases and normal bone marrow of the spine using dynamic contrast-enhanced MR imaging.Diagnostic examination performance by using microvascular leakage, cerebral blood volume, and blood flow derived from 3-T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in the differentiation of glioblastoma multiforme and brActive MR-temperature feedback control of dynamic interstitial ultrasound therapy in brain: in vivo experiments and modeling in native and coagulated tissues.A study of patients with brain metastases as the initial manifestation of their systemic cancer in a Chinese population.Comparison of contrast-enhanced modified T1-weighted 3D TSE black-blood and 3D MP-RAGE sequences for the detection of cerebral metastases and brain tumours.Half brain irradiation in a murine model of breast cancer brain metastasis: magnetic resonance imaging and histological assessments of dose-response.
P2860
Q29248327-676946C6-8C61-4659-88D6-D6A4E2FA5698Q30422997-8E238DB2-5961-48A7-819F-F56E4AB3531FQ30782393-7928EF14-6E81-405C-BF60-4E4C8EAA8BAEQ33897079-E466AEA7-CAD1-45DA-986E-040F7C9927E9Q33941578-CB513627-E213-48FA-80AA-EAD8FCD97B6AQ35602796-478F3BF3-02E5-4CA4-AE80-572B55FD9A71Q36682422-3917DA4C-BAF6-477D-9B5B-3033917E9975Q37346039-7CF9403A-8588-4024-87F0-BFB7CA2BEB96Q37601465-6D2C3658-7FBF-458C-9383-F016E8AE31E0Q37641235-43D698CF-4CF5-4110-9379-8E042334340EQ37687512-FDD10C89-320B-4464-A74C-DABE412999FCQ37747457-3CDF8395-FEA4-4B77-9598-E7EE9A47E298Q37809862-3F30134D-5391-4B35-9C42-68D9650FFDD6Q38105945-41F14A12-112C-49B5-8365-8E448FEC347DQ38106370-25B3B7E9-75D6-450A-A0ED-3525E7704840Q38109519-E9AC1F27-1A14-4D00-9129-44338B709E6DQ38953017-66506A7D-0A1C-4A03-B720-8D8AA919D9D1Q39038900-EC6ED96B-E82D-4496-94E5-FB3086F56873Q39803034-D394A65E-2265-48EC-BEC5-10972F303A8DQ40160872-F9357E50-69CA-4533-8BBA-724E6F96D292Q41111356-D2D3FA14-CCCC-4D15-A982-2AE7DE5F53C4Q47812904-EA813405-8B95-4805-BC6E-D621296D3DEEQ48130398-05183034-DFEB-4E04-A79C-28B5CBBA0B24Q48566086-3B25C229-3761-400B-A32C-BF47B088077EQ51746643-911E1A58-D9D1-4E77-B523-1C2DEB76FBADQ52150030-B8BFF904-5D52-4030-A921-7B21E465CECDQ54974333-B185E35B-86D0-4CAB-A426-2EF42F1C074A
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Current management of metastatic brain disease
@ast
Current management of metastatic brain disease
@en
type
label
Current management of metastatic brain disease
@ast
Current management of metastatic brain disease
@en
prefLabel
Current management of metastatic brain disease
@ast
Current management of metastatic brain disease
@en
P2860
P1433
P1476
Current management of metastatic brain disease
@en
P2093
Lauren E Abrey
Tulika Ranjan
P2860
P2888
P304
P356
10.1016/J.NURT.2009.04.012
P577
2009-07-01T00:00:00Z
P5875
P6179
1041142730